Literature DB >> 1971873

Obstetric complications in DSM-III schizophrenics and their siblings.

J M Eagles1, I Gibson, M H Bremner, F Clunie, K P Ebmeier, N C Smith.   

Abstract

Blind to the adult diagnosis, the birth records of 27 patients fulfilling DSM-III criteria for schizophrenia and those of their healthy siblings were examined. A significant excess of obstetric complications was seen in the schizophrenic subjects.

Entities:  

Mesh：

Year:  1990        PMID： 1971873     DOI： 10.1016/0140-6736(90)91136-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  6 in total

1.  When and how does schizophrenia produce social deficits?

Authors:  H Häfner; B Nowotny; W Löffler; W an der Heiden; K Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

2.  A case-control study of obstetric complications and later autistic disorder.

Authors:  E Cryan; M Byrne; A O'Donovan; E O'Callaghan
Journal:  J Autism Dev Disord       Date:  1996-08

3.  Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study.

Authors:  E O'Callaghan; T Gibson; H A Colohan; P Buckley; D G Walshe; C Larkin; J L Waddington
Journal:  BMJ       Date:  1992-11-21

4.  Prenatal exposure to influenza epidemics and risk of mental retardation.

Authors:  N Takei; G Murray; E O'Callaghan; P C Sham; G Glover; R M Murray
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

5.  Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample.

Authors:  D J Done; E C Johnstone; C D Frith; J Golding; P M Shepherd; T J Crow
Journal:  BMJ       Date:  1991-06-29

Review 6.  Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications.

Authors:  Vijay A Mittal; Lauren M Ellman; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2008-07-17       Impact factor: 9.306
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.